BioCentury
ARTICLE | Clinical News

Alnylam preclinical data

January 21, 2013 8:00 AM UTC

In a mouse model of beta-thalassemia, ALN-TMP reduced the severity of anemia as demonstrated by an approximate 1 g/dL increase in total hemoglobin and a 50% reduction in circulating erythropoietin lev...